Tumor vaccine strategies after allogeneic T-cell depleted bone marrow transplantation
Allogeneic bone marrow transplantation is currently restricted to hematological malignancies because of a lack of anti-tumor activity against solid cancers. We have tested a novel treatment strategy to stimulate specific anti-tumor activity against a solid tumor after transplantation by vaccination with irradiated tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor. Using the B16 melanoma model, we found that vaccination elicited potent anti-tumor activity in recipients of syngeneic bone marrow transplantation in a time dependent fashion, and that immune reconstitution was critical for the development of anti-tumor activity. Vaccination did not stimulate anti-tumor immunity after allogeneic bone marrow transplantation because of the post-transplantation immunodeficiency associated with graft-versus-host disease. Remarkably, vaccination was effective in stimulating potent and long-lasting anti-tumor activity in recipients of T cell-depleted allogeneic bone marrow. Thus T cells derived from donor stem cells were able to recognize tumor antigens even though they remained tolerant to host histocompatibility antigens. Donor leukocyte infusion from a donor immunized with the recipient-derived B16 vaccines enhanced clinical activity of tumor vaccines without exacerbating graft-versus-host disease and CD4+ T cells are essential for this enhancement. These results demonstrate that vaccination of both donors and recipients can stimulate potent anti-tumor effects without the induction of graft-versus-host disease, and this strategy has important implications for the treatment of patients with solid malignancies.
Main Author: | Ferrara,James L.M. |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular
2002
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842002000300011 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The South African Bone Marrow Registry (SABMR) and allogeneic bone marrow transplantation
by: Ruff,Paul, et al.
Published: (2008) -
Evaluation of early hospital discharge after allogeneic bone marrow transplantation for chronic myeloid leukemia
by: Nicolau,José Eduardo, et al.
Published: (2007) -
Sinusitis in patients undergoing allogeneic bone marrow transplantation – a review
by: Drozd-Sokolowska,Joanna Ewa, et al.
Published: (2017) -
The availability of full match sibling donors and feasibility of allogeneic bone marrow transplantation in Brazil
by: Eid,K.A.B., et al.
Published: (2003) -
Treating horse chronic laminitis with allogeneic bone marrow mesenchymal stem cells
by: García-Lascuráin,Alma A, et al.
Published: (2021)